"Anti-COVID-19
pill available next month in the PH"
By: Patricia
B. Inocencio
On October
13, 2020, Faberco Life Science Inc. was appointed to distribute the
Molnuprivari 200mg capsule in the Philippines through Aurobindo Pharma Ltd., a
partner manufacturer of Merck & Co. and the developer of the first oral
drug. It was clinically proven to reduce the risk of hospitalization and death
from COVID-19, which may arrive in the country in November.
Faberco
stated that they partnered with RiteMed Philippines Inc.
COVID-19
pills are coming to hospitals, medical institutions, and treatment sites once Compassionate Special Permits (CSP) and
Philippine Food and Drug Administration approved.
“We are
confident that through the distribution channels of RiteMed, Molnupiravir will
reach healthcare facilities throughout the country faster, giving more
Filipinos access to this lifesaving drug the soonest possible time,” said
Kishore Hemlani, founder of Faberco.
“This
partnership with Faberco puts RiteMed in a good position to help more Filipinos
survive the pandemic and is aligned with our mission to provide access to
essential medicines by partnering with like-minded doctors and healthcare
facilities,” said RiteMed president Jose Maria Ochave.
PFDA
Director-General Eric Domingo also stated earlier that the oral antiviral drug
can be used by doctors in hospitals for COVID treatment through the CSP.
Department of Health (DOH) Undersecretary Maria Rosario Vergeire, promised
earlier that they will make efforts to "have better access" to the
antiviral pill.
Source:
INQUIRER
No comments:
Post a Comment